Table 4 Participant attitude toward OAC therapy in NVAF patients
Attitude items | Frequency | Percentage % |
|---|---|---|
The type of atrial fibrillation would affect doctors’ initiate anticoagulant therapy and choose oral anticoagulants | ||
Strongly disagree | 47 | 9.5 |
Somewhat disagree | 64 | 12.9 |
Not sure | 118 | 23.7 |
Somewhat agree | 177 | 35.6 |
Strongly agree | 91 | 18.3 |
It is necessary to use the stroke score tool to assess the risk of stroke in AF patients before anticoagulant therapy | ||
Strongly disagree | 1 | 0.2 |
Somewhat disagree | 12 | 2.4 |
Not sure | 64 | 12.9 |
Somewhat agree | 186 | 37.4 |
Strongly agree | 234 | 47.1 |
It is necessary to use the bleeding score tool to assess the risk of bleeding in AF patients before anticoagulant therapy | ||
Strongly disagree | 5 | 1.0 |
Somewhat disagree | 8 | 1.6 |
Not sure | 55 | 11.1 |
Somewhat agree | 161 | 32.4 |
Strongly agree | 268 | 53.9 |
I am more concerned about the risk of bleeding in AF patients than the risk of stroke in AF patients | ||
Strongly disagree | 52 | 10.5 |
Somewhat disagree | 132 | 26.6 |
Not sure | 122 | 24.5 |
Somewhat agree | 143 | 28.8 |
Strongly agree | 48 | 9.7 |
I think it’s important for AF patients to “understand the risk of stroke and bleeding in patients with AF” | ||
Strongly disagree | 4 | 0.8 |
Somewhat disagree | 8 | 1.6 |
Not sure | 48 | 9.7 |
Somewhat agree | 155 | 31.2 |
Strongly agree | 282 | 56.7 |
I think it’s important for AF patients to “reduce the risk of stroke and bleeding due to atrial fibrillation” | ||
Strongly disagree | 3 | 0.6 |
Somewhat disagree | 10 | 2.0 |
Not sure | 51 | 10.3 |
Somewhat agree | 151 | 30.4 |
Strongly agree | 282 | 56.7 |
It is safe to maintain the INR between 2.0 and 3.0 for warfarin anticoagulation therapy in NVAF patients | ||
Strongly disagree | 18 | 3.6 |
Somewhat disagree | 31 | 6.2 |
Not sure | 122 | 24.5 |
Somewhat agree | 171 | 34.4 |
Strongly agree | 155 | 31.2 |
It is necessary to tell AF patients about medication and food that affect warfarin's anticoagulant effects | ||
Strongly disagree | 1 | 0.2 |
Somewhat disagree | 10 | 2.0 |
Not sure | 57 | 11.5 |
Somewhat agree | 134 | 27.0 |
Strongly agree | 295 | 59.4 |
I fully understand the views of AF patients on reducing the risk of stroke and bleeding caused by warfarin therapy | ||
Strongly disagree | 1 | 0.2 |
Somewhat disagree | 20 | 4.0 |
Not sure | 70 | 14.1 |
Somewhat agree | 228 | 45.9 |
Strongly agree | 178 | 35.8 |
I think the new oral anticoagulant (NOAC) has a lower risk of bleeding than warfarin | ||
Strongly disagree | 6 | 1.2 |
Somewhat disagree | 22 | 4.4 |
Not sure | 130 | 26.2 |
Somewhat agree | 183 | 36.8 |
Strongly agree | 156 | 31.4 |
I think the new oral anticoagulant (NOAC) is easier to administer than warfarin | ||
Strongly disagree | 5 | 1.0 |
Somewhat disagree | 32 | 6.4 |
Not sure | 141 | 28.4 |
Somewhat agree | 143 | 28.8 |
Strongly agree | 176 | 35.4 |
I hope to have more Knowledge to discuss the advantages and disadvantages of stroke, bleeding risk and anticoagulation r | ||
Strongly disagree | 1 | 0.2 |
Somewhat disagree | 10 | 2.0 |
Not sure | 60 | 12.1 |
Somewhat agree | 159 | 32.0 |
Strongly agree | 267 | 53.7 |
I think doctors can improve the standard anticoagulant treatment rate in AF patients after training atrial fibrillation | ||
Strongly disagree | 1 | 0.2 |
Somewhat disagree | 4 | 0.8 |
Not sure | 47 | 9.5 |
Somewhat agree | 128 | 25.8 |
Strongly agree | 317 | 63.8 |